MedTrace Logo

Effects of a Supplement Containing Fucoidan on Basal Body Temperature

NCT01399216 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2012-12-17

No results posted yet for this study

Summary

We aim to determine whether a supplement containing fucoidan isolated from Mekabu (sporophyll of Undaria pinnatifida), EPA, and DHA has effects of elevating basal body temperature in subjects with low basal body temperature.

Conditions

  • Low Basal Body Temperature

Interventions

DIETARY_SUPPLEMENT

Supplement containing fucoidan, EPA, and DHA

75 mg fucoidan per day, for 8 weeks

DIETARY_SUPPLEMENT

Placebo

for 8 weeks

Sponsors & Collaborators

  • Three Peace Co., Ltd., Japan

    collaborator UNKNOWN

  • Hiroshima University

    lead OTHER

Principal Investigators

  • Fumiko Higashikawa, PhD · Hiroshima University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
55 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01399216 on ClinicalTrials.gov